4 results
P0321 - Changes in quality of life in ADHD-patients treated with extended-release Methylphenidate (OROS®-MPH) - results from an open-label naturalistic study
-
- Journal:
- European Psychiatry / Volume 23 / Issue S2 / April 2008
- Published online by Cambridge University Press:
- 16 April 2020, p. S394
-
- Article
-
- You have access
- Export citation
P0282 - Treatment with OROS®-Methylphenidate in adolescents is associated with an improvement in functioning and quality of life - A post-hoc analysis
-
- Journal:
- European Psychiatry / Volume 23 / Issue S2 / April 2008
- Published online by Cambridge University Press:
- 16 April 2020, p. S383
-
- Article
-
- You have access
- Export citation
P0320 - OROS®-MPH in adolescents with ADHD transitioning from Atomoxetine or ER-MPH (medikinet retard®) - a post-hoc analysis
-
- Journal:
- European Psychiatry / Volume 23 / Issue S2 / April 2008
- Published online by Cambridge University Press:
- 16 April 2020, p. S394
-
- Article
-
- You have access
- Export citation
Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate
-
- Journal:
- Psychological Medicine / Volume 42 / Issue 1 / January 2012
- Published online by Cambridge University Press:
- 01 June 2011, pp. 195-204
-
- Article
-
- You have access
- Open access
- HTML
- Export citation